SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Beyond Air, Inc. (XAIR) (CIK 0001641631) (XAIR) — Jun 14, 2017

Beyond Air, Inc. (XAIR) (CIK 0001641631)
Date: June 14, 2017 · CIK: 0001641631 · Accession: 0001178913-17-001817

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-218626

Date
June 16, 2017
Author
By
Form
CORRESP
Company
Beyond Air, Inc. (XAIR) (CIK 0001641631)

Letter

AIT Therapeutics, Inc.

2 Ilan Ramon, Science Park

Ness Ziona, 7403635 Israel

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Amanda Ravitz

Tom Jones

Re: AIT Therapeutics, Inc.

Registration Statement on Form S-1

File No. 333-218626

Ladies and Gentlemen:

AIT Therapeutics, Inc., a Delaware corporation (the "Company"), hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (the "Registration Statement") so that such Registration Statement shall become effective at 4:00 p.m. (Washington, D.C. time) on Friday, June 16, 2017 or as soon thereafter as practicable.

Please provide a copy of the Commission's order declaring the Registration Statement effective to Amir Avniel at the address first set forth above.

Respectfully yours,
AIT Therapeutics, Inc.

Show Raw Text
CORRESP
1
filename1.htm

AIT Therapeutics, Inc.

2 Ilan Ramon, Science Park

Ness Ziona, 7403635 Israel

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention:     Amanda Ravitz

                       Tom Jones

Re:          AIT Therapeutics, Inc.

                Registration Statement on Form S-1

                File No. 333-218626

Ladies and Gentlemen:

AIT Therapeutics, Inc., a Delaware corporation (the "Company"), hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (the "Registration Statement") so that such Registration Statement shall become effective at 4:00 p.m. (Washington, D.C. time) on Friday, June 16, 2017 or as soon thereafter as practicable.

Please provide a copy of the Commission's order declaring the Registration Statement effective to Amir Avniel at the address first set forth above.

Respectfully yours,

AIT Therapeutics, Inc.

By:

/s/ Amir Avniel

Amir Avniel

President and Chief Operating Officer